Nephro Care P/E Ratio
NEPHROCARE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
25.95
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
25.95
Current Price
₹
EPS (TTM)
₹2.38
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
58.44
Sector Median
39.27
Sector Rank
#11 of 47
Sector Percentile
23.4%
Key P/E Ratio Insights for Nephro Care
- Stock appears overvalued with PE of 25.95, suggesting caution for new investments
- Trading at discount to sector average PE of 58.44
Related Pages for Nephro Care
Additional stock information and data for NEPHROCARE
Sector P/E Ratio Comparison
Comparing Nephro Care with other companies in Healthcare Services sector
Sector Average
58.44
Sector Median
39.27
Lowest P/E
6.2
Highest P/E
375.68
Companies
47
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.2 | ₹89 | Low |
| Deccan Health Care | DECCAN | 8.98 | ₹18 | Low |
| Nidan Labs & Healthcare | NIDAN | 10.21 | ₹19 | Low |
| Shanmuga Hospital | SHANMUGA | 11.83 | ₹47 | Low |
| One Global Service Provi… | ONEGLOBAL | 16.94 | ₹1,055 | Moderate |
| Abate AS Industries | ABATEAS | 17.6 | ₹182 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 18.41 | ₹1,046 | Moderate |
| Tejnaksh Healthcare | TEJNAKSH | 19.16 | ₹23 | Moderate |
| Asarfi Hospital | ASARFI | 19.77 | ₹348 | Moderate |
| Clinitech Laboratory | CTLLAB | 20.23 | ₹8 | Moderate |